Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1α

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 154-160

  Shenkman, Boris ^a   Brill, A ^b   Brill, G ^c   Lider, O ^d   Savion, N ^e   Varon, D ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Platelets; RANTES; SDF 1

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; FIBRINOGEN; MONOKINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E1; RANTES; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANALYZER; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MEMBRANE BINDING; MONOLAYER CULTURE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA; TURBIDIMETRY; BLOOD; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ADHESIVENESS; VASCULAR ENDOTHELIUM;

BLOOD PLATELETS; CELLS, CULTURED; CHEMOKINES, CXC; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; RANTES; RECEPTORS, CXCR4;

EID: 4444265635     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00527.x     Document Type: Article

References (35)

1. Wang JF, Liu ZY, Groopman JE. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998; 92 756-64.
2. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000; 96: 4046-54.
3. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder J-M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-92.
4. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol 1995; 107: 541-6.
5. Kowalska MA, Ratajczak MZ, Majka M, Jin J, Kunapuli S, Brass L, Poncz M. Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets. Blood 2000; 96 50-7.
6. Abi-Younes S, Si-Tahar M, Luster AD. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb Res 2001; 101: 279-89.
7. Gear AR, Suttitanamongkol S, Viisoreanu D, Polanowska-Grabowska RK, Raha S, Camerini D. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 2001; 97: 937-45.
8. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chanyry D, Suzuki R, Yoshie O. Presence of high contents of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110: 139-46.
9. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schomig A, Neumann F. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000; 148: 75-85.
10. Boelen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001; 11: 403-17.
11. von Hunderlshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1718-20.
12. Page CP. Platelets as inflammatory cells. Immunopharmacol 1989; 17: 51-9.
13. Damaz JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Froland SS, Aukrust P. CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes. Cardiovasc Res 2000; 45: 267-9.
14. Abi-Yoynes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000; 86: 131-8.
15. Suttitanamongkol S, Gear AR. ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC. FEBS Lett 2001; 490: 84-7.
16. Siess W, Grunberg B, Luber K. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Adv Exp Med Biol 1993; 344: 229-35.
17. 2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. Biochem Biophys Res Commun 1984; 120: 579-85.
18. Hecht I, Cahalon L, Hershkoviz R, Lahat A, Franitza S, Lider O. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int Immunol 2003; 15: 29-38.
19. Honczarenko M, Le Y, Glodek AM, Majka M, Campbell JJ, Ratajczak MZ, Silberstein LE. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 2002; 100: 2321-9.
20. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing factor VII-related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734-7.
21. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-94.
22. Michelson AD, Barnard MR. Thrombin induced changes in platelet membrane glycoproteins Ib, IX and IIb-IIIa complex. Blood 1987; 70: 1673-8.
23. Warkentin TE, Powling MJ, Hardisty RM. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. Br J Haematol 1990; 76: 387-94.
24. Kowalska MA, Ratajczak J, Hoxie J, Brass LF, Gewirtz A. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haenatol 1999; 104: 220-9.
25. Law DA, Nannizzi-Alaimo L, Phillips DR. Outside-in signal transduction: αIIb/β3 (GpIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 1996; 271: 10811-5.
26. Varon D, Lashevski I, Brenner B, Beyar R, Lanir N, Tamarin I, Savion N. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am Heart J 1998; 135 S187-93.
27. Shenkman B, Savion N, Dardik R, Tamarin I, Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the Cone and Plate(let) Analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 2000; 99: 353-61.
28. Shenkman B, Schneiderman J, Tamarin I, Kotev-Emeth S, Savion N, Varon D. Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods. Thromb Res 2001; 102: 311-7.
29. Kaplan JE, Moon DG, Weston LK, Minnear FL, Del Veccio PJ, Shepard JM, Fenton JW. Platelets adhere to thrombin-treated endothelial cells in vitro. Am J Physiol 1989; 257: H423-33.
30. Li JM, Podolsky RS, Rohrer MJ, Cutler BS, Massie MT, Barnard MR, Michelson AD. Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. J Surg Res 1996; 61: 543-8.
31. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Ando H, Kawai Y, Atanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-40.
32. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611-6.
33. Keh D, Gerlach M, Kurer I, Seiler S, Kerner T, Falke KJ, Gerlach H. The effect of nitric oxide (NO) on platelet membrane receptor expression during activation with human α-thrombin. Blood Coagul Fibrinol 1996; 7: 615-24.
34. Deng HK, Liu R, Ellmeier W, Choe H, Unutmaz D, Burkhart M, Marzio PDi, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. Identification of major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-6.
35. Richardson RM, Ali H, Tomhave ED, Haribabu B, Snyderman R. Cross-desensitization of chemoattractant receptor occurs at multiple levels. J Biol Chem 1995; 270: 27829-33.